Multidrug-resistant Acinetobacter meningitis treated by intrathecal colistin

Annals of Indian Academy of Neurology

Volumn 20, Issue 1, 2017, Pages 74-75

  Singh, Rajesh ^a   Bhoi, Sanjeev ^a   Kalita, Jayantee ^a   Misra, Usha ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; COLISTIN; VANCOMYCIN;

ACINETOBACTER INFECTION; ACINETOBACTER LWOFFII; ADULT; ANTIBIOTIC SENSITIVITY; BACTERIAL MENINGITIS; BACTERIUM CULTURE; BRAIN VENTRICLE HEMORRHAGE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DEVICE REMOVAL; DRUG DOSE INCREASE; FEMALE; FEVER; HEMIPARESIS; HUMAN; LETTER; MIDDLE AGED; MULTIDRUG RESISTANT ACINETOBACTER MENINGITIS; NONHUMAN; STIFF NECK; UNCONSCIOUSNESS; VENTRICULOSTOMY; VENTRICULOSTOMY CATHETER;

EID: 85012951223     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.199908     Document Type: Letter

References (7)

1. Gales AC, Jones RN, Sader HS. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: Report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect 2006;12:315-21.
2. Jones RN, Sader HS, Beach ML. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY antimicrobial surveillance program (1997-2001). Int J Antimicrob Agents 2003;22:551-6.
3. Falagas ME, Bliziotis IA, Tam VH. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: A systematic review of the available evidence. Int J Antimicrob Agents 2007;29:9-25.
4. Fotakopoulos G, Makris D, Chatzi M, Tsimitrea E, Zakynthinos E, et al. Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin. Acta Neurochir (Wien) 2016;158:603-10.
5. De Bonis P Lofrese G, Scoppettuolo G, Spanu T, Cultrera R, Labonia M, et al. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis. Eur J Neurol 2016;23:68-75.
6. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004 1;39:1267-84.
7. Vasen W, Desmery P, Ilutovich S, Di Martino A. Intrathecal use of colistin. J Clin Microbiol 2000;38:3523.